The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older Men<subtitle>The Aging in the Chianti Area (InCHIANTI) Study</subtitle>
Open accessAbstract
BACKGROUND: Aging in men is characterized by a progressive decline in levels of anabolic hormones, such as testosterone, insulinlike growth factor 1 (IGF-1), and dehydroepiandrosterone sulfate (DHEA-S). We hypothesized that in older men a parallel age-associated decline in bioavailable testosterone, IGF-1, and DHEA-S secretion is associated with higher mortality independent of potential confounders. METHODS: Testosterone, IGF-1, DHEA-S, and demographic features were evaluated in a representative sample of 410 men 65 years and older enrolled in the Aging in the Chianti Area (InCHIANTI) study. A total of 126 men died during the 6-year follow-up. Thresholds for lowest-quartile definitions were 70 ng/dL (to convert to nanomoles per liter, multiply by 0.0347) for bioavailable testosterone, 63.9 ng/mL (to convert to nanomoles per liter, multiply by 0.131) for total IGF-1, and 50 microg/dL (to convert to micromoles per liter, multiply by 0.027) for DHEA-S. Men were divided into 4 groups: no hormone in the lowest quartile (reference) and 1, 2, and 3 hormones in the lowest quartiles. Kaplan-Meier survival and Cox proportional hazards models adjusted for confounders were used in the analysis. RESULTS: Compared with men with levels of all 3 hormones above the lowest quartiles, having 1, 2, and 3 dysregulated hormones was associated with hazard ratios for mortality of 1.47 (95% confidence interval [CI], 0.88-2.44), 1.85 (95% CI, 1.04-3.30), and 2.29 (95% CI, 1.12-4.68), respectively (test for trend, P <.001). In the fully adjusted analysis, only men with 3 anabolic hormone deficiencies had a significant increase in mortality (hazard ratio, 2.44; 95% CI, 1.09-5.46 (test for trend, P <.001). CONCLUSIONS: Age-associated decline in anabolic hormone levels is a strong independent predictor of mortality in older men. Having multiple hormonal deficiencies rather than a deficiency in a single anabolic hormone is a robust biomarker of health status in older persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.
Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152405 · Cited by 681
DHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566
Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522
Laughlin, G. A., Barrett-Connor, E., Criqui, M. H., & Kritz-Silverstein, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030967 · Cited by 374 · cited 1×
“Evidence has indicated that low testosterone, IGF-1, and DHEA-S levels are good predictors of cardiovascular disease and diabetes in men.(5,10,26) Furthermore, we have previously shown that a low testosterone level is inversely related with inflammatory markers and predicts the development of anemia in the older popul…”
BackgroundLeng, S. X., Cappola, A. R., Andersen, R. E., Blackman, M. R., Koenig, K., Blair, M., & Walston, J. D. (2004) · Aging Clinical and Experimental Research · doi:10.1007/bf03324545 · Cited by 270
Maggio, M., Basaria, S., Ble, A., Lauretani, F., Bandinelli, S., Ceda, G. P., Valenti, G., Ling, S. M., & Ferrucci, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1097 · Cited by 200
Self-citation
Cited by
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Levine, M. E., Suarez, J. A., Brandhorst, S., Balasubramanian, P., Cheng, C.-W., Madia, F., Fontana, L., Mirisola, M. G., Guevara-Aguirre, J., Wan, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.006 · Cited by 910
Psychological and metabolic stress: A recipe for accelerated cellular aging?
Epel, E. S. (2009) · Hormones · doi:10.14310/horm.2002.1217 · Cited by 423
The role of androgens and estrogens on healthy aging and longevity
Horstman, A. M., Dillon, E. L., Urban, R. J., & Sheffield-Moore, M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls068 · Cited by 396
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341
Haring, R., Volzke, H., Steveling, A., Krebs, A., Felix, S. B., Schofl, C., Dorr, M., Nauck, M., & Wallaschofski, H. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq009 · Cited by 311
Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis
Ruige, J. B., Mahmoud, A. M., De Bacquer, D., & Kaufman, J.-M. (2011) · Heart · doi:10.1136/hrt.2010.210757 · Cited by 302
Volpato, S., Bianchi, L., Cherubini, A., Landi, F., Maggio, M., Savino, E., Bandinelli, S., Ceda, G. P., Guralnik, J. M., Zuliani, G., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt149 · Cited by 297
Self-citationLower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men
Yeap, B. B., Hyde, Z., Almeida, O. P., Norman, P. E., Chubb, S. A. P., Jamrozik, K., Flicker, L., & Hankey, G. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2416 · Cited by 275
Aversa, A., Bruzziches, R., Francomano, D., Rosano, G., Isidori, A. M., Lenzi, A., & Spera, G. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01931.x · Cited by 265
Fabbri, E., An, Y., Zoli, M., Simonsick, E. M., Guralnik, J. M., Bandinelli, S., Boyd, C. M., & Ferrucci, L. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu127 · Cited by 240
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Milman, S., Huffman, D. M., & Barzilai, N. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.014 · Cited by 150
Labrie, F., Martel, C., & Balser, J. (2011) · Menopause · doi:10.1097/gme.0b013e3181e195a6 · Cited by 143
Sex Steroid Hormone Concentrations and Risk of Death in US Men
Menke, A., Guallar, E., Rohrmann, S., Nelson, W. G., Rifai, N., Kanarek, N., Feinleib, M., Michos, E. D., Dobs, A., & Platz, E. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp415 · Cited by 141
Male Sexuality and Cardiovascular Risk. A Cohort Study in Patients with Erectile Dysfunction
Corona, G., Monami, M., Boddi, V., Cameron-Smith, M., Lotti, F., De Vita, G., Melani, C., Balzi, D., Sforza, A., Forti, G., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01744.x · Cited by 134
Corona, G., Monami, M., Boddi, V., Cameron-Smith, M., Fisher, A. D., De Vita, G., Melani, C., Balzi, D., Sforza, A., Forti, G., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01690.x · Cited by 128
Association of Sex Hormones, Aging, and Atrial Fibrillation in Men: The Framingham Heart Study
Magnani, J. W., Moser, C. B., Murabito, J. M., Sullivan, L. M., Wang, N., Ellinor, P. T., Vasan, R. S., Benjamin, E. J., & Coviello, A. D. (2014) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001322 · Cited by 112
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Kolosova, N. G., Stefanova, N. A., Muraleva, N. A., & Skulachev, V. P. (2012) · Aging · doi:10.18632/aging.100493 · Cited by 53
Is Obesity a Further Cardiovascular Risk Factor in Patients with Erectile Dysfunction?
Corona, G., Monami, M., Boddi, V., Balzi, D., Melani, C., Federico, N., Balzi, D., Sforza, A., Rotella, C. M., Forti, G., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01839.x · Cited by 35
Platz, E. A. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.104901 · Cited by 25
Serum Dehydroepiandrosterone Sulfate and Adverse Health Outcomes in Older Men and Women
Forti, P., Maltoni, B., Olivelli, V., Pirazzoli, G. L., Ravaglia, G., & Zoli, M. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1248 · Cited by 24
Metadata
- Authors
- Maggio, M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-11-12
- Volume
- 167
- Issue
- 20
- Pages
- 2249
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2162093804
- Cited by
- 200
- References
- 7
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.